Randomized, open labelled, cross over deposition study of Tobramycin 100 PARI nebulized with eFlow versus TOBI nebulized with PARI LC PLUS in subjects with CF.
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Tobramycin (Primary)
- Indications Pseudomonal infections
- Focus Therapeutic Use
- 26 Jul 2011 New trial record